Table 17.
Occurrence of resistance (%) to selected antimicrobials in Salmonella spp. from broiler flocks, using harmonised ECOFFs, 22 EU MSs, 2016
| Country | N | GEN | CHL | AMP | CTX | CAZ | MEM | TGC | NAL | CIP | AZM | COL | SMX | TMP | TET |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Austria | 179 | 0 | 0 | 1.7 | 0 | 0 | 0 | 0 | 53.6 | 53.6 | 0 | 0 | 53.6 | 0.6 | 53.6 |
| Belgium | 123 | 2.4 | 3.3 | 34.1 | 0 | 0 | 0 | 0 | 46.3 | 46.3 | 0 | 1.6 | 64.2 | 29.3 | 35 |
| Bulgariaa | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66.7 | 66.7 | 0 | 0 | 66.7 | 33.3 | 66.7 |
| Croatia | 125 | 0 | 0 | 2.4 | 0 | 0 | 0 | 0 | 73.6 | 72.8 | 0 | 0 | 15.2 | 0 | 15.2 |
| Cyprus | 24 | 8.3 | 0 | 12.5 | 0 | 0 | 0 | 4.2 | 95.8 | 100 | 0 | 0 | 95.8 | 91.7 | 95.8 |
| Czech Republic | 91 | 4.4 | 1.1 | 14.3 | 1.1 | 0 | 0 | 2.2 | 20.9 | 24.2 | 0 | 13.2 | 12.1 | 2.2 | 12.1 |
| Denmark | 20 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 75 |
| Finland a | 1 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| France | 29 | 0 | 3.4 | 13.8 | 0 | 0 | 0 | 0 | 10.3 | 10.3 | 0 | 0 | 13.8 | 6.9 | 6.9 |
| Germany | 24 | 0 | 16.7 | 20.8 | 0 | 0 | 0 | 4.2 | 29.2 | 33.3 | 8.3 | 25 | 37.5 | 8.3 | 37.5 |
| Greece | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.6 | 51.9 | 3.7 | 0 | 3.7 | 0 | 0 |
| Hungary | 170 | 0.6 | 0 | 10 | 1.8 | 1.8 | 0 | 7.6 | 86.5 | 87.6 | 0.6 | 0 | 71.8 | 0 | 75.3 |
| Ireland | 14 | 0 | 0 | 7.1 | 0 | 0 | 0 | 0 | 0 | 7.1 | 0 | 0 | 14.3 | 0 | 7.1 |
| Italy | 25 | 0 | 12 | 48 | 12 | 12 | 0 | 0 | 60 | 60 | 0 | 12 | 56 | 52 | 60 |
| Malta | 80 | 28.8 | 5 | 42.5 | 2.5 | 1.3 | 0 | 3.8 | 48.8 | 50 | 0 | 0 | 73.8 | 6.3 | 53.8 |
| Poland | 84 | 0 | 1.2 | 10.7 | 0 | 0 | 0 | 0 | 57.1 | 67.9 | 1.2 | 4.8 | 27.4 | 0 | 29.8 |
| Portugal | 51 | 7.8 | 3.9 | 23.5 | 2 | 2 | 0 | 0 | 5.9 | 21.6 | 5.9 | 2 | 17.6 | 5.9 | 19.6 |
| Romania | 170 | 7.6 | 1.8 | 29.4 | 0.6 | 0.6 | 0 | 4.1 | 45.9 | 57.6 | 0 | 5.3 | 51.8 | 15.9 | 41.8 |
| Slovakia | 53 | 1.9 | 3.8 | 20.8 | 1.9 | 1.9 | 0 | 1.9 | 81.1 | 83 | 1.9 | 0 | 34 | 3.8 | 35.8 |
| Slovenia | 85 | 0 | 0 | 20 | 0 | 0 | 0 | 2.4 | 96.5 | 96.5 | 0 | 0 | 96.5 | 1.2 | 95.3 |
| Spain | 169 | 25.4 | 6.5 | 30.2 | 1.2 | 0 | 0 | 0.6 | 36.7 | 55.6 | 0 | 0.6 | 37.3 | 8.3 | 25.4 |
| United Kingdom | 170 | 1.2 | 0.6 | 3.5 | 0 | 0 | 0 | 0 | 3.5 | 8.8 | 0 | 0 | 18.2 | 17.1 | 19.4 |
| Total (22 MSs) | 1,717 | 5.6 | 2.2 | 17.1 | 0.8 | 0.6 | 0 | 1.8 | 48.3 | 53.8 | 0.5 | 2.2 | 44.1 | 9.3 | 40.1 |
| Iceland | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norway | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ECOFFs: epidemiological cut‐off values; EUCAST: European Committee on Antimicrobial Susceptibility Testing; N: number of isolates tested; MSs: Member States; GEN: gentamicin; CHL: chloramphenicol; AMP: ampicillin; CTX: cefotaxime; CAZ: Ceftazidime; MEM: meropenem; TGC: tigecycline, NAL: nalidixic acid; CIP: ciprofloxacin; AZM: azithromycin; COL: colistin; SMX: sulfamethoxazole; TMP: trimethoprim; TET: tetracycline.
a
The occurrence of resistance is assessed on less than 10 isolates.